Skip to main content
Clinical Trials/EUCTR2005-005709-50-DE
EUCTR2005-005709-50-DE
Active, not recruiting
Phase 1

Extracorporal shock wave therapy for induction of therapeutic neovascularization and homing of bone marrow progenitor cells in patients with chronic ischemic heart disease - Cell-Wave-CHF

Cardiology, University of Frankfurt0 sites100 target enrollmentJanuary 9, 2006

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Cardiology, University of Frankfurt
Enrollment
100
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 9, 2006
End Date
May 31, 2011
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Cardiology, University of Frankfurt

Eligibility Criteria

Inclusion Criteria

  • ·Patients with chronic ischemic cardiomyopathy
  • ·s/p anterior myocardial infarction \> 3 months
  • ·18\-80 years
  • ·Male or female
  • ·Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes

Exclusion Criteria

  • ·Myocardial infarction \< 3 months
  • ·ventricular thrombus
  • ·acute infection or fever
  • ·chronic inflammatory diseases ( M. Crohn, Rheumatoid Arthritis)
  • ·HIV Infection or active Hepatitis
  • ·Neoplastic Diseases without complete remission in the last 5 years
  • ·Stroke within 3 months
  • ·renal insufficiency (Kreatinin \> 2 mg/dl) before treatment
  • ·Liver disease (GOT \> 2x upper limit, or spontaneous INR \> 1,5\).
  • ·Anemia (Hemoglobin \< 10 mg/dl)

Outcomes

Primary Outcomes

Not specified

Similar Trials